Home / About Novasep / Media & Events / Case studies

Case studies

Successful cGMP conjugation of a Novel ADC for phase I clinical trials

Successful cGMP conjugation of a Novel ADC for phase I clinical trials

15 Feb 2018

Novasep was approached by a top 10 pharmaceutical company to help with the manufacture of a cGMP antibody drug conjugate. The ADC was in clinical trial Phase I to treat solid tumors, and the customer required a quantity of ADC within 4 months starting from 100g monoclonal antibody.



You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!